Clinical Trials · NCT03070704
Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India
- Phase
- N/A
- Recruitment status
- Withdrawn
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 0
- Start date
- Aug 2017
- Locations
- See registry
- Primary endpoint
- Incidence of treatment emergent Adverse Events (AEs)